EUVIMEDEUVIMED entdecken
Crossref

NGS Analysis of the BRCA1/BRCA2 Variants in the Ovarian Cancer Patients at High versus Low Risk of Mutation

Dinh-Toi Chu

Thai Journal of Obstetrics and Gynaecology · 01.01.2024

DOI: 10.14456/tjog.2024.41 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thai Journal of Obstetrics and Gynaecology, erschienen am 01.01.2024. Verfasst von Dinh-Toi Chu. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The pathogenic variant in breast cancer susceptibility gene 1/2 (BRCA1/2) is related to the risk of ovarian cancer, which is one of the most common cancers among women worldwide. Here, we aimed to understand the variants of these genes among Vietnamese population to improve early detection and diagnosis as well as treatment decisions. Materials and Methods: BRCA1/2 genes of tumor tissue from 33 ovarian cancer patients in high-risk and low-risk of mutation groups were sequenced by next-generation sequencing (NGS) using the BRCAaccuTestTM PLUS kit.

Results

Among a total of 33 distinguished variants detected, we found 5 pathogenic and likely pathogenic (P/LP) variants, including c.1801_1808delCACAATTC, c.1016delA, c.1673_1674delAA, c.928C>T in BRCA1 and c.2865delC in BRCA2 with a frequency of 3.03%, except for c.1801_1808delCACAATTC (6.06%). All variants led to defects in coding protein. c.1801_1808delCACAATTC variant in BRCA1 and c.2865delC in BRCA2 was firstly introduced. The prevalence of BRCA1/2 P/LP variants in the high-risk group was 22.73%, while this figure for the low-risk group was 9.09%. No statistically significant difference in other clinical features was found between P/LP variant-carried and non-P/LP variant-carried patients apart from age and comorbidities.

Conclusions

This study provided precious data for BRCA1/2 variant mapping among Vietnamese ovarian cancer patients.

Schlagwörter

BRCA1BRCA2germline mutationsovarian cancerhigh-risk patientslow-risk patientsnext-generation sequencing

Zitieren

APA

Chu, D. (2024). NGS Analysis of the BRCA1/BRCA2 Variants in the Ovarian Cancer Patients at High versus Low Risk of Mutation. Thai Journal of Obstetrics and Gynaecology. https://doi.org/10.14456/tjog.2024.41

Vancouver

Chu D. NGS Analysis of the BRCA1/BRCA2 Variants in the Ovarian Cancer Patients at High versus Low Risk of Mutation. Thai Journal of Obstetrics and Gynaecology. 2024. doi:10.14456/tjog.2024.41

BibTeX
@article{Chu2024,
  author = {Chu, Dinh-Toi},
  title = {NGS Analysis of the BRCA1/BRCA2 Variants in the Ovarian Cancer Patients at High versus Low Risk of Mutation},
  journal = {Thai Journal of Obstetrics and Gynaecology},
  year = {2024},
  doi = {10.14456/tjog.2024.41}
}
Kostenlos starten →